PRESS RELEASE: Elucigene Diagnostics Partner With Genomax Technologies Manchester, UK, 24th January 2017 Elucigene Diagnostics, developer and distributor of leading prenatal and human genetics diagnostics have today partnered with Genomax Technologies, to bring Elucigene leading brands such as CFEU2v1 and QST*R, to Singapore, Malaysia and Thailand. Genomax Technologies (Singapore), founded in 2003, provide life science […]
UPCOMING WEBINAR Register Here Webinar Title: Review of Guidelines for Interpreting Somatic Hypermutation Status in Chronic Lymphocytic Leukemia in the Era of High-Throughput Sequencing Summary: In this presentation, Siby Sebastian will review and discuss current guidelines in evaluating, interpreting, and reporting somatic hypermutation (SHM) status in chronic lymphocytic leukemia (CLL) with the focus on laboratory experience […]
UPCOMING WEBINAR Register Now Webinar Title: Enabling novel technologies to effectively develop T and NK cell-based therapeutic products Summary: T cell and NK cells are the most promising cell types for providing treatments that could potentially offer cures to cancer and other diseases. Based on FDA guidelines, the manufacturing process for these immune cells must have […]
WEBINAR INVITATION Register Now Thursday, Mar 24, 2022 10:00 AM – 11:30 AM SGT Reliable FcRn binding assays are used in both discovery and development of therapeutic antibodies as predictive tools for in vivo half-life. Join us for this educational webinar as we show two orthogonal assays for measuring binding of antibodies to FcRn. We […]
Summary: Register for our upcoming webinar to hear Dr. Meng Ling Moi discuss meeting the challenges faced while responding to COVID-19 in Southeast Asia and Japan. She’ll describe epidemic patterns among regions, associated host-immune responses, and how these provide insights into vaccination strategies in response to the emergence of new variants. In this webinar you […]
Summary: 10x Genomics and BioLegend are excited to co-host a webinar led by Felix Nettersheim, MD, postdoctoral researcher in the group of Professor Klaus Ley at La Jolla Institute for Immunology, San Diego. Dr. Nettersheim’s studies focus on understanding how metabolic reprogramming of immune cells affects atherosclerosis, the major underlying pathology of cardiovascular disease. Single […]
